Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins

Neurology

Volumn 50, Issue 6, 1998, Pages 1580-1585

  Carmelli, Dorit ^a   Swan, G E ^a   Reed, T ^b   Miller, B ^c   Wolf, P A ^f   Jarvik, G P ^d   Schellenberg, G D ^e  

^a SRI INTERNATIONAL   (United States)

^b INDIANA UNIVERSITY   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; COGNITION; CORONARY RISK; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; TWINS;

EID: 0031776860     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.6.1580     Document Type: Article

References (35)

1. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
2. Chartier-Harlin MC, Parfitt M, Legrain S. Apolipoprotein E, ∈4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:568-574.
3. Van Duijn CM, De Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78.
4. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E ∈4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-242.
5. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-349.
6. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphism in apolipoprotein E, A4, and H on quantitative traits related to risk of cardiovascular disease. Arterioscler Thromb 1991;11:1330-1348.
7. Lendon CL, Ashall F, Goate AM. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 1997;227: 825-831.
8. Reed T, Carmelli D, Swan GE, et al. Lower cognitive performance in normal adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol 1994;51:1189-1192.
9. Feskens E, Havekes LM, Kalmijn S, et al. Apolipoprotein E4 allele and cognitive decline in elderly men. BMJ 1994;309: 1202-1206.
10. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele ∈4, dementia and cognitive decline in a population sample. Lancet 1995;346:1387-1390.
11. Blass JP. Pathophysiology of the Alzheimer's syndrome. Neurology 1993;43(suppl):25S-38S.
12. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease. Neurology 1995;45:1092-1096.
13. Slooter AJC, Tang M-X, van Duijn CM, et al. Apolipoprotein E ∈4 and the risk of dementia with stroke. JAMA 1997;277:818-821.
14. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996;27:2230-2235.
15. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-154.
16. Feinleib M, Garrison RJ, Fabsitz RR, et al. The NHLBI twin study of cardiovascular risk factors: methodology and summary of results. Am J Epidemiol 1977;106:284-295.
17. Jablon S, Neel JV, Gershowitz H, Atkinson GF. The NAS-NRC twin panel: methods of construction of the panel, zygosity diagnosis and proposed use. Am J Hum Genet 1967;19:133-161.
18. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Wechsler D. Manual: Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corp; 1974.
20. Eslinger PJ, Damasio AR, Benton AL. The Iowa battery for mental decline. Iowa City, IA: University of Iowa; 1984.
21. Reed T, Quiroga J, Selby JV, et al. Concordance of ischemic heart disease in the NHLBI Twin Study after 14-18 years of follow-up. J Clin Epidemiol 1991;44:797-805.
22. Selby JV, Newman B, Quiroga J, Christian JC, Austin MA, Fabsitz RR. Concordance for dyslipidemic hypertension in male twins. JAMA 1991;265:2079-2084.
23. Swan GE, Carmelli D, Reed T, Jarvik GP. The relationship between apolipoprotein E4 and neuropsychological test performance in nondemented older adults. J Int Neuropsychol Soc 1997;3:71. Abstract.
24. Swan GE, Carmelli D, LaRue A. Performance on the Digit Symbol Substitution Test and 5-year mortality in the Western Collaborative Group Study. Am J Epidemiol 1995;141:41-49.
25. Carmelli D, Swan GE, LaRue A, Eslinger PJ. Correlates of change in cognitive function in survivors from the Western Collaborative Group Study. Neuroepidemiology 1997;16:285-295.
26. Kalmijn S, Feskens EJM, Launer LJ, Stijnen T, Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995;38: 1096-1102.
27. Kuusisto J, Koivisto K, Mykkanene L, et al. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension 1993;22:771-779.
28. Perlmutter LC, Hakami MK, Hodgson-Harrington C, Ginsberg J, Singer DE, Nathan DM. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 1984;77:1043-1048.
29. Elias MF, Schultz NR, Robbins NR, Elias PK. A longitudinal study of neuropsychological performance by hypertensives and normotensives: a third measurement point. J Gerontol Psychol Sci 1989;45:25-28.
30. Launer LJ, Masaki K, Petrovich H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995;274:1846-1851.
31. Swan GE, Carmelli D, LaRue A. Relationship between blood pressure during middle age and cognitive impairment in old age: the Western Collaborative Group Study. Aging Neuropsychol Cogn 1996;3:241-250.
32. Van Swieten JC, Geyskes GG, Derix MMA, et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 1991;30:825-830.
33. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury and apolipoprotein e4 in patients with Alzheimer's disease. Neurology 1995;45:555-557.
34. Katzman R, Galasko D, Saito T, et al. Apolipoprotein-e4 and head trauma: synergistic or additive risks? Neurology 1996; 46:889-891.
35. Alberts MJ, Graffagnino C, McClenny C, et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet 1995; 346:575. Letter.